nodes	percent_of_prediction	percent_of_DWPC	metapath
Probenecid—ABCC3—hematologic cancer	0.139	0.474	CbGaD
Probenecid—SLC22A1—hematologic cancer	0.097	0.33	CbGaD
Probenecid—ABCC6—Daunorubicin—hematologic cancer	0.0312	0.0628	CbGbCtD
Probenecid—ALB—hematologic cancer	0.0295	0.1	CbGaD
Probenecid—ABCB1—hematologic cancer	0.0282	0.0958	CbGaD
Probenecid—ABCC6—Teniposide—hematologic cancer	0.0271	0.0545	CbGbCtD
Probenecid—ABCC4—Tioguanine—hematologic cancer	0.0213	0.043	CbGbCtD
Probenecid—ABCC5—Mercaptopurine—hematologic cancer	0.0184	0.0371	CbGbCtD
Probenecid—ABCC11—Methotrexate—hematologic cancer	0.0137	0.0277	CbGbCtD
Probenecid—ABCC6—Vinblastine—hematologic cancer	0.0133	0.0267	CbGbCtD
Probenecid—ABCC1—Idarubicin—hematologic cancer	0.013	0.0262	CbGbCtD
Probenecid—ABCC6—Cisplatin—hematologic cancer	0.0122	0.0245	CbGbCtD
Probenecid—ABCC6—Etoposide—hematologic cancer	0.0119	0.0241	CbGbCtD
Probenecid—SLCO1A2—Chlorambucil—hematologic cancer	0.0116	0.0234	CbGbCtD
Probenecid—ABCC5—Cisplatin—hematologic cancer	0.00929	0.0187	CbGbCtD
Probenecid—ABCC1—Daunorubicin—hematologic cancer	0.00919	0.0185	CbGbCtD
Probenecid—ABCC4—Mercaptopurine—hematologic cancer	0.00886	0.0178	CbGbCtD
Probenecid—SLC22A2—Daunorubicin—hematologic cancer	0.00833	0.0168	CbGbCtD
Probenecid—ABCC6—Doxorubicin—hematologic cancer	0.00815	0.0164	CbGbCtD
Probenecid—SLC22A2—Cytarabine—hematologic cancer	0.00735	0.0148	CbGbCtD
Probenecid—SLC22A2—Cladribine—hematologic cancer	0.00694	0.014	CbGbCtD
Probenecid—ABCC2—Daunorubicin—hematologic cancer	0.0068	0.0137	CbGbCtD
Probenecid—SLC22A1—Cytarabine—hematologic cancer	0.00639	0.0129	CbGbCtD
Probenecid—SLC22A2—Imatinib—hematologic cancer	0.00638	0.0129	CbGbCtD
Probenecid—ABCC3—Vincristine—hematologic cancer	0.00626	0.0126	CbGbCtD
Probenecid—SLC22A1—Cladribine—hematologic cancer	0.00603	0.0121	CbGbCtD
Probenecid—SLCO1C1—Methotrexate—hematologic cancer	0.00603	0.0121	CbGbCtD
Probenecid—SLC16A1—Methotrexate—hematologic cancer	0.00603	0.0121	CbGbCtD
Probenecid—ABCC3—Cisplatin—hematologic cancer	0.00584	0.0118	CbGbCtD
Probenecid—ABCC3—Etoposide—hematologic cancer	0.00574	0.0116	CbGbCtD
Probenecid—ABCC1—Mitoxantrone—hematologic cancer	0.00559	0.0113	CbGbCtD
Probenecid—SLC22A1—Imatinib—hematologic cancer	0.00555	0.0112	CbGbCtD
Probenecid—SLC22A8—Mercaptopurine—hematologic cancer	0.00554	0.0111	CbGbCtD
Probenecid—ABCC1—Epirubicin—hematologic cancer	0.00452	0.00911	CbGbCtD
Probenecid—ABCC1—Irinotecan—hematologic cancer	0.0044	0.00886	CbGbCtD
Probenecid—SLCO1A2—Prednisolone—hematologic cancer	0.00439	0.00883	CbGbCtD
Probenecid—SLCO1A2—Prednisone—hematologic cancer	0.00414	0.00834	CbGbCtD
Probenecid—ABCC3—Doxorubicin—hematologic cancer	0.00391	0.00788	CbGbCtD
Probenecid—ABCC1—Vinblastine—hematologic cancer	0.00391	0.00787	CbGbCtD
Probenecid—CYP2C9—Bexarotene—hematologic cancer	0.0039	0.00785	CbGbCtD
Probenecid—ABCC1—Vincristine—hematologic cancer	0.00384	0.00774	CbGbCtD
Probenecid—ABCC3—Methotrexate—hematologic cancer	0.00379	0.00763	CbGbCtD
Probenecid—ABCB1—Lenalidomide—hematologic cancer	0.00378	0.00762	CbGbCtD
Probenecid—SLC22A2—Vinblastine—hematologic cancer	0.00355	0.00714	CbGbCtD
Probenecid—ABCC1—Etoposide—hematologic cancer	0.00352	0.00709	CbGbCtD
Probenecid—CYP2C8—Bortezomib—hematologic cancer	0.00343	0.0069	CbGbCtD
Probenecid—ABCC2—Irinotecan—hematologic cancer	0.00326	0.00656	CbGbCtD
Probenecid—SLC22A2—Cisplatin—hematologic cancer	0.00325	0.00655	CbGbCtD
Probenecid—ALB—Imatinib—hematologic cancer	0.00325	0.00654	CbGbCtD
Probenecid—CYP2C9—Idarubicin—hematologic cancer	0.00323	0.00651	CbGbCtD
Probenecid—SLC22A11—Methotrexate—hematologic cancer	0.00311	0.00627	CbGbCtD
Probenecid—SLC22A7—Methotrexate—hematologic cancer	0.00296	0.00597	CbGbCtD
Probenecid—ABCC4—Methotrexate—hematologic cancer	0.0029	0.00583	CbGbCtD
Probenecid—ABCC2—Vinblastine—hematologic cancer	0.00289	0.00583	CbGbCtD
Probenecid—CYP2C19—Bortezomib—hematologic cancer	0.00287	0.00579	CbGbCtD
Probenecid—ABCC2—Vincristine—hematologic cancer	0.00285	0.00573	CbGbCtD
Probenecid—ABCC2—Cisplatin—hematologic cancer	0.00265	0.00534	CbGbCtD
Probenecid—CYP2C8—Ifosfamide—hematologic cancer	0.00263	0.00529	CbGbCtD
Probenecid—ABCC2—Etoposide—hematologic cancer	0.00261	0.00525	CbGbCtD
Probenecid—SLCO1A2—Dexamethasone—hematologic cancer	0.00259	0.00521	CbGbCtD
Probenecid—CYP2C19—Thalidomide—hematologic cancer	0.0025	0.00504	CbGbCtD
Probenecid—ABCC1—Doxorubicin—hematologic cancer	0.0024	0.00484	CbGbCtD
Probenecid—CYP2C9—Bortezomib—hematologic cancer	0.00239	0.00481	CbGbCtD
Probenecid—CYP2C19—Teniposide—hematologic cancer	0.00239	0.00481	CbGbCtD
Probenecid—ABCC1—Methotrexate—hematologic cancer	0.00233	0.00469	CbGbCtD
Probenecid—CYP2C8—Nilotinib—hematologic cancer	0.00228	0.00459	CbGbCtD
Probenecid—CYP3A4—Bexarotene—hematologic cancer	0.00227	0.00457	CbGbCtD
Probenecid—ABCB1—Daunorubicin—hematologic cancer	0.00222	0.00447	CbGbCtD
Probenecid—CYP2C19—Ifosfamide—hematologic cancer	0.0022	0.00444	CbGbCtD
Probenecid—ABCB1—Alitretinoin—hematologic cancer	0.00217	0.00438	CbGbCtD
Probenecid—ABCC2—Dexamethasone—hematologic cancer	0.00214	0.00432	CbGbCtD
Probenecid—ALB—Prednisone—hematologic cancer	0.00214	0.00431	CbGbCtD
Probenecid—CYP3A4—Lomustine—hematologic cancer	0.00211	0.00424	CbGbCtD
Probenecid—CYP3A4—Busulfan—hematologic cancer	0.00211	0.00424	CbGbCtD
Probenecid—CYP2C19—Imatinib—hematologic cancer	0.00211	0.00424	CbGbCtD
Probenecid—CYP2C9—Thalidomide—hematologic cancer	0.00208	0.00419	CbGbCtD
Probenecid—SLCO1A2—Methotrexate—hematologic cancer	0.00208	0.00419	CbGbCtD
Probenecid—ALB—Irinotecan—hematologic cancer	0.00203	0.00409	CbGbCtD
Probenecid—CYP2C9—Teniposide—hematologic cancer	0.00199	0.004	CbGbCtD
Probenecid—PANX1—hematopoietic system—hematologic cancer	0.00197	0.0528	CbGeAlD
Probenecid—CYP3A4—Thiotepa—hematologic cancer	0.00188	0.00378	CbGbCtD
Probenecid—CYP2C9—Ifosfamide—hematologic cancer	0.00183	0.00369	CbGbCtD
Probenecid—SLC22A8—Methotrexate—hematologic cancer	0.00181	0.00364	CbGbCtD
Probenecid—ABCC2—Doxorubicin—hematologic cancer	0.00178	0.00358	CbGbCtD
Probenecid—CYP2C9—Imatinib—hematologic cancer	0.00175	0.00353	CbGbCtD
Probenecid—ABCC2—Methotrexate—hematologic cancer	0.00172	0.00347	CbGbCtD
Probenecid—ABCB1—Imatinib—hematologic cancer	0.0017	0.00342	CbGbCtD
Probenecid—CYP2C9—Nilotinib—hematologic cancer	0.00159	0.0032	CbGbCtD
Probenecid—ABCB1—Nilotinib—hematologic cancer	0.00154	0.00311	CbGbCtD
Probenecid—ABCB1—Vinorelbine—hematologic cancer	0.00153	0.00308	CbGbCtD
Probenecid—CYP3A4—Methoxsalen—hematologic cancer	0.00146	0.00294	CbGbCtD
Probenecid—ABCC11—gonad—hematologic cancer	0.00144	0.0385	CbGeAlD
Probenecid—CYP3A4—Bortezomib—hematologic cancer	0.00139	0.0028	CbGbCtD
Probenecid—CYP2C19—Prednisone—hematologic cancer	0.00139	0.00279	CbGbCtD
Probenecid—ABCB1—Dasatinib—hematologic cancer	0.00136	0.00275	CbGbCtD
Probenecid—ABCB1—Mitoxantrone—hematologic cancer	0.00135	0.00271	CbGbCtD
Probenecid—CYP3A4—Daunorubicin—hematologic cancer	0.00133	0.00268	CbGbCtD
Probenecid—PANX1—blood—hematologic cancer	0.0013	0.035	CbGeAlD
Probenecid—SLC22A6—Methotrexate—hematologic cancer	0.00126	0.00254	CbGbCtD
Probenecid—CYP2C8—Etoposide—hematologic cancer	0.00126	0.00253	CbGbCtD
Probenecid—ABCB1—Betamethasone—hematologic cancer	0.0012	0.00242	CbGbCtD
Probenecid—ABCB1—Gemcitabine—hematologic cancer	0.00119	0.0024	CbGbCtD
Probenecid—ABCB1—Prednisolone—hematologic cancer	0.00119	0.00239	CbGbCtD
Probenecid—SLC2A9—blood—hematologic cancer	0.00118	0.0317	CbGeAlD
Probenecid—CYP3A4—Cytarabine—hematologic cancer	0.00117	0.00236	CbGbCtD
Probenecid—CYP3A4—Teniposide—hematologic cancer	0.00115	0.00233	CbGbCtD
Probenecid—PANX1—lung—hematologic cancer	0.00114	0.0307	CbGeAlD
Probenecid—ABCB1—Prednisone—hematologic cancer	0.00112	0.00225	CbGbCtD
Probenecid—ABCC6—hematopoietic system—hematologic cancer	0.00108	0.0291	CbGeAlD
Probenecid—PANX1—testis—hematologic cancer	0.00108	0.0289	CbGeAlD
Probenecid—ALB—Methotrexate—hematologic cancer	0.00107	0.00216	CbGbCtD
Probenecid—CYP3A4—Ifosfamide—hematologic cancer	0.00107	0.00215	CbGbCtD
Probenecid—ABCB1—Irinotecan—hematologic cancer	0.00106	0.00214	CbGbCtD
Probenecid—SLC2A9—lung—hematologic cancer	0.00104	0.0278	CbGeAlD
Probenecid—ABCC11—testis—hematologic cancer	0.00103	0.0277	CbGeAlD
Probenecid—CYP2C8—Dexamethasone—hematologic cancer	0.00103	0.00208	CbGbCtD
Probenecid—ABCC6—Podofilox—Teniposide—hematologic cancer	0.00102	0.627	CbGdCrCtD
Probenecid—CYP3A4—Imatinib—hematologic cancer	0.00102	0.00205	CbGbCtD
Probenecid—SLC2A9—testis—hematologic cancer	0.000978	0.0262	CbGeAlD
Probenecid—CYP3A4—Ruxolitinib—hematologic cancer	0.000959	0.00193	CbGbCtD
Probenecid—ABCB1—Vinblastine—hematologic cancer	0.000944	0.0019	CbGbCtD
Probenecid—ABCB1—Vincristine—hematologic cancer	0.000928	0.00187	CbGbCtD
Probenecid—CYP3A4—Nilotinib—hematologic cancer	0.000925	0.00186	CbGbCtD
Probenecid—CYP3A4—Vinorelbine—hematologic cancer	0.000917	0.00185	CbGbCtD
Probenecid—CYP2C9—Cisplatin—hematologic cancer	0.000891	0.0018	CbGbCtD
Probenecid—CYP2C19—Dexamethasone—hematologic cancer	0.000866	0.00174	CbGbCtD
Probenecid—ABCB1—Cisplatin—hematologic cancer	0.000865	0.00174	CbGbCtD
Probenecid—ABCB1—Etoposide—hematologic cancer	0.00085	0.00171	CbGbCtD
Probenecid—CYP3A4—Triamcinolone—hematologic cancer	0.000839	0.00169	CbGbCtD
Probenecid—CYP3A4—Dasatinib—hematologic cancer	0.000818	0.00165	CbGbCtD
Probenecid—CYP3A4—Mitoxantrone—hematologic cancer	0.000808	0.00163	CbGbCtD
Probenecid—SLC16A7—gonad—hematologic cancer	0.000801	0.0215	CbGeAlD
Probenecid—PANX1—lymph node—hematologic cancer	0.000782	0.021	CbGeAlD
Probenecid—SLC10A1—gonad—hematologic cancer	0.000748	0.0201	CbGeAlD
Probenecid—CYP2C9—Dexamethasone—hematologic cancer	0.00072	0.00145	CbGbCtD
Probenecid—CYP3A4—Betamethasone—hematologic cancer	0.00072	0.00145	CbGbCtD
Probenecid—ABCC6—blood—hematologic cancer	0.000718	0.0193	CbGeAlD
Probenecid—CYP3A4—Prednisolone—hematologic cancer	0.00071	0.00143	CbGbCtD
Probenecid—SLC2A9—lymph node—hematologic cancer	0.000709	0.019	CbGeAlD
Probenecid—ABCB1—Dexamethasone—hematologic cancer	0.000699	0.00141	CbGbCtD
Probenecid—SLC16A7—blood—hematologic cancer	0.000698	0.0187	CbGeAlD
Probenecid—CYP3A4—Prednisone—hematologic cancer	0.000671	0.00135	CbGbCtD
Probenecid—SLC16A1—hematopoietic system—hematologic cancer	0.00067	0.018	CbGeAlD
Probenecid—CYP3A4—Irinotecan—hematologic cancer	0.000636	0.00128	CbGbCtD
Probenecid—ABCC6—lung—hematologic cancer	0.00063	0.0169	CbGeAlD
Probenecid—ABCC3—hematopoietic system—hematologic cancer	0.000619	0.0166	CbGeAlD
Probenecid—SLC16A7—lung—hematologic cancer	0.000612	0.0164	CbGeAlD
Probenecid—ABCC6—Podofilox—Etoposide—hematologic cancer	0.000608	0.373	CbGdCrCtD
Probenecid—ABCB1—Doxorubicin—hematologic cancer	0.00058	0.00117	CbGbCtD
Probenecid—SLC16A7—testis—hematologic cancer	0.000577	0.0155	CbGeAlD
Probenecid—CYP3A4—Vinblastine—hematologic cancer	0.000565	0.00114	CbGbCtD
Probenecid—ABCB1—Methotrexate—hematologic cancer	0.000562	0.00113	CbGbCtD
Probenecid—CYP3A4—Vincristine—hematologic cancer	0.000556	0.00112	CbGbCtD
Probenecid—SLC10A1—testis—hematologic cancer	0.000539	0.0145	CbGeAlD
Probenecid—SLCO1A2—hematopoietic system—hematologic cancer	0.000531	0.0142	CbGeAlD
Probenecid—ABCC4—hematopoietic system—hematologic cancer	0.000511	0.0137	CbGeAlD
Probenecid—SLC16A1—gonad—hematologic cancer	0.00051	0.0137	CbGeAlD
Probenecid—CYP3A4—Etoposide—hematologic cancer	0.000509	0.00103	CbGbCtD
Probenecid—SLCO1C1—testis—hematologic cancer	0.000507	0.0136	CbGeAlD
Probenecid—SLC22A8—hematopoietic system—hematologic cancer	0.000507	0.0136	CbGeAlD
Probenecid—SLC22A7—testis—hematologic cancer	0.00048	0.0129	CbGeAlD
Probenecid—ABCC5—bone marrow—hematologic cancer	0.000472	0.0127	CbGeAlD
Probenecid—ABCC5—lung—hematologic cancer	0.000428	0.0115	CbGeAlD
Probenecid—CYP2C19—hematopoietic system—hematologic cancer	0.000425	0.0114	CbGeAlD
Probenecid—CYP3A4—Dexamethasone—hematologic cancer	0.000419	0.000843	CbGbCtD
Probenecid—SLC16A7—lymph node—hematologic cancer	0.000418	0.0112	CbGeAlD
Probenecid—ABCC3—blood—hematologic cancer	0.00041	0.011	CbGeAlD
Probenecid—ABCC5—testis—hematologic cancer	0.000404	0.0108	CbGeAlD
Probenecid—SLC16A1—lung—hematologic cancer	0.000389	0.0104	CbGeAlD
Probenecid—CYP2C8—hematopoietic system—hematologic cancer	0.000371	0.00994	CbGeAlD
Probenecid—SLC16A1—testis—hematologic cancer	0.000367	0.00985	CbGeAlD
Probenecid—SLCO1C1—lymph node—hematologic cancer	0.000367	0.00985	CbGeAlD
Probenecid—SLC22A1—blood—hematologic cancer	0.000365	0.00979	CbGeAlD
Probenecid—ABCC3—lung—hematologic cancer	0.000359	0.00964	CbGeAlD
Probenecid—CYP3A4—Doxorubicin—hematologic cancer	0.000347	0.0007	CbGbCtD
Probenecid—ABCC3—testis—hematologic cancer	0.000339	0.00909	CbGeAlD
Probenecid—ABCC4—blood—hematologic cancer	0.000338	0.00907	CbGeAlD
Probenecid—SLC22A8—blood—hematologic cancer	0.000336	0.009	CbGeAlD
Probenecid—CYP2C9—hematopoietic system—hematologic cancer	0.000329	0.00883	CbGeAlD
Probenecid—ABCC2—blood—hematologic cancer	0.000328	0.00878	CbGeAlD
Probenecid—ABCC4—bone marrow—hematologic cancer	0.000327	0.00878	CbGeAlD
Probenecid—SLCO1A2—lung—hematologic cancer	0.000308	0.00827	CbGeAlD
Probenecid—ABCC4—lung—hematologic cancer	0.000297	0.00796	CbGeAlD
Probenecid—ABCC5—lymph node—hematologic cancer	0.000293	0.00785	CbGeAlD
Probenecid—SLCO1A2—testis—hematologic cancer	0.000291	0.0078	CbGeAlD
Probenecid—ALB—testis—hematologic cancer	0.000289	0.00775	CbGeAlD
Probenecid—ABCC1—blood—hematologic cancer	0.000289	0.00774	CbGeAlD
Probenecid—CYP2C19—blood—hematologic cancer	0.000281	0.00755	CbGeAlD
Probenecid—ABCC4—testis—hematologic cancer	0.00028	0.00751	CbGeAlD
Probenecid—ABCC2—testis—hematologic cancer	0.000271	0.00727	CbGeAlD
Probenecid—SLC16A1—lymph node—hematologic cancer	0.000266	0.00714	CbGeAlD
Probenecid—SLC22A5—blood—hematologic cancer	0.000254	0.00681	CbGeAlD
Probenecid—ABCC1—lung—hematologic cancer	0.000253	0.00678	CbGeAlD
Probenecid—CYP3A4—hematopoietic system—hematologic cancer	0.000251	0.00674	CbGeAlD
Probenecid—ABCC3—lymph node—hematologic cancer	0.000246	0.00659	CbGeAlD
Probenecid—CYP2C8—blood—hematologic cancer	0.000246	0.00659	CbGeAlD
Probenecid—ABCC1—testis—hematologic cancer	0.000239	0.0064	CbGeAlD
Probenecid—SLC22A5—lung—hematologic cancer	0.000222	0.00597	CbGeAlD
Probenecid—CYP2C9—blood—hematologic cancer	0.000218	0.00585	CbGeAlD
Probenecid—SLC22A5—testis—hematologic cancer	0.00021	0.00563	CbGeAlD
Probenecid—ALB—lymph node—hematologic cancer	0.00021	0.00562	CbGeAlD
Probenecid—CYP2C8—testis—hematologic cancer	0.000203	0.00545	CbGeAlD
Probenecid—ABCC4—lymph node—hematologic cancer	0.000203	0.00544	CbGeAlD
Probenecid—ABCC2—lymph node—hematologic cancer	0.000196	0.00527	CbGeAlD
Probenecid—ABCB1—hematopoietic system—hematologic cancer	0.000178	0.00477	CbGeAlD
Probenecid—ABCC1—lymph node—hematologic cancer	0.000173	0.00464	CbGeAlD
Probenecid—CYP3A4—blood—hematologic cancer	0.000166	0.00446	CbGeAlD
Probenecid—SLC22A5—lymph node—hematologic cancer	0.000152	0.00408	CbGeAlD
Probenecid—ABCB1—gonad—hematologic cancer	0.000135	0.00363	CbGeAlD
Probenecid—ABCB1—blood—hematologic cancer	0.000118	0.00316	CbGeAlD
Probenecid—ABCB1—bone marrow—hematologic cancer	0.000114	0.00306	CbGeAlD
Probenecid—ABCB1—lung—hematologic cancer	0.000103	0.00277	CbGeAlD
Probenecid—ABCB1—testis—hematologic cancer	9.74e-05	0.00261	CbGeAlD
Probenecid—Hypersensitivity—Vinorelbine—hematologic cancer	7.91e-05	0.000827	CcSEcCtD
Probenecid—Decreased appetite—Vincristine—hematologic cancer	7.9e-05	0.000826	CcSEcCtD
Probenecid—Dizziness—Lenalidomide—hematologic cancer	7.9e-05	0.000826	CcSEcCtD
Probenecid—Urticaria—Thalidomide—hematologic cancer	7.87e-05	0.000823	CcSEcCtD
Probenecid—Body temperature increased—Thalidomide—hematologic cancer	7.84e-05	0.000819	CcSEcCtD
Probenecid—Vomiting—Melphalan—hematologic cancer	7.81e-05	0.000817	CcSEcCtD
Probenecid—Dizziness—Hydroxyurea—hematologic cancer	7.79e-05	0.000814	CcSEcCtD
Probenecid—Pruritus—Bortezomib—hematologic cancer	7.78e-05	0.000813	CcSEcCtD
Probenecid—Pain—Vincristine—hematologic cancer	7.77e-05	0.000813	CcSEcCtD
Probenecid—Dermatitis—Melphalan—hematologic cancer	7.74e-05	0.000809	CcSEcCtD
Probenecid—Pruritus—Bleomycin—hematologic cancer	7.72e-05	0.000807	CcSEcCtD
Probenecid—Decreased appetite—Mitoxantrone—hematologic cancer	7.69e-05	0.000805	CcSEcCtD
Probenecid—Decreased appetite—Irinotecan—hematologic cancer	7.69e-05	0.000805	CcSEcCtD
Probenecid—Nausea—Vinblastine—hematologic cancer	7.67e-05	0.000802	CcSEcCtD
Probenecid—Anorexia—Cisplatin—hematologic cancer	7.66e-05	0.000801	CcSEcCtD
Probenecid—Vomiting—Lenalidomide—hematologic cancer	7.59e-05	0.000794	CcSEcCtD
Probenecid—Pruritus—Vinorelbine—hematologic cancer	7.59e-05	0.000794	CcSEcCtD
Probenecid—Pain—Irinotecan—hematologic cancer	7.57e-05	0.000791	CcSEcCtD
Probenecid—Pain—Mitoxantrone—hematologic cancer	7.57e-05	0.000791	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Epirubicin—hematologic cancer	7.56e-05	0.000791	CcSEcCtD
Probenecid—Hypersensitivity—Thiotepa—hematologic cancer	7.55e-05	0.00079	CcSEcCtD
Probenecid—Alopecia—Betamethasone—hematologic cancer	7.54e-05	0.000788	CcSEcCtD
Probenecid—Alopecia—Dexamethasone—hematologic cancer	7.54e-05	0.000788	CcSEcCtD
Probenecid—Body temperature increased—Carmustine—hematologic cancer	7.53e-05	0.000787	CcSEcCtD
Probenecid—Dermatitis—Lenalidomide—hematologic cancer	7.52e-05	0.000787	CcSEcCtD
Probenecid—Decreased appetite—Gemcitabine—hematologic cancer	7.49e-05	0.000784	CcSEcCtD
Probenecid—Urticaria—Alitretinoin—hematologic cancer	7.49e-05	0.000784	CcSEcCtD
Probenecid—Vomiting—Hydroxyurea—hematologic cancer	7.49e-05	0.000783	CcSEcCtD
Probenecid—Headache—Lenalidomide—hematologic cancer	7.48e-05	0.000782	CcSEcCtD
Probenecid—Body temperature increased—Alitretinoin—hematologic cancer	7.45e-05	0.00078	CcSEcCtD
Probenecid—Dermatitis—Hydroxyurea—hematologic cancer	7.42e-05	0.000776	CcSEcCtD
Probenecid—Urticaria—Ifosfamide—hematologic cancer	7.4e-05	0.000774	CcSEcCtD
Probenecid—Headache—Hydroxyurea—hematologic cancer	7.38e-05	0.000772	CcSEcCtD
Probenecid—Pain—Gemcitabine—hematologic cancer	7.37e-05	0.000771	CcSEcCtD
Probenecid—Body temperature increased—Ifosfamide—hematologic cancer	7.37e-05	0.000771	CcSEcCtD
Probenecid—Anaphylactic shock—Etoposide—hematologic cancer	7.36e-05	0.00077	CcSEcCtD
Probenecid—Hypersensitivity—Thalidomide—hematologic cancer	7.3e-05	0.000764	CcSEcCtD
Probenecid—Nausea—Melphalan—hematologic cancer	7.3e-05	0.000763	CcSEcCtD
Probenecid—Dizziness—Bortezomib—hematologic cancer	7.27e-05	0.00076	CcSEcCtD
Probenecid—Anaphylactic shock—Prednisolone—hematologic cancer	7.26e-05	0.000759	CcSEcCtD
Probenecid—Pruritus—Thiotepa—hematologic cancer	7.25e-05	0.000758	CcSEcCtD
Probenecid—Body temperature increased—Vincristine—hematologic cancer	7.18e-05	0.000751	CcSEcCtD
Probenecid—Dizziness—Vinorelbine—hematologic cancer	7.1e-05	0.000742	CcSEcCtD
Probenecid—Nausea—Lenalidomide—hematologic cancer	7.09e-05	0.000742	CcSEcCtD
Probenecid—ABCB1—lymph node—hematologic cancer	7.06e-05	0.00189	CbGeAlD
Probenecid—Urticaria—Mitoxantrone—hematologic cancer	7.03e-05	0.000735	CcSEcCtD
Probenecid—Anorexia—Etoposide—hematologic cancer	7.02e-05	0.000734	CcSEcCtD
Probenecid—Hypersensitivity—Carmustine—hematologic cancer	7.01e-05	0.000733	CcSEcCtD
Probenecid—Pruritus—Thalidomide—hematologic cancer	7.01e-05	0.000733	CcSEcCtD
Probenecid—Body temperature increased—Mitoxantrone—hematologic cancer	7e-05	0.000732	CcSEcCtD
Probenecid—Body temperature increased—Irinotecan—hematologic cancer	7e-05	0.000732	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Doxorubicin—hematologic cancer	7e-05	0.000732	CcSEcCtD
Probenecid—Nausea—Hydroxyurea—hematologic cancer	6.99e-05	0.000732	CcSEcCtD
Probenecid—Vomiting—Bortezomib—hematologic cancer	6.99e-05	0.000731	CcSEcCtD
Probenecid—Decreased appetite—Cisplatin—hematologic cancer	6.98e-05	0.00073	CcSEcCtD
Probenecid—Hypersensitivity—Alitretinoin—hematologic cancer	6.95e-05	0.000727	CcSEcCtD
Probenecid—Vomiting—Bleomycin—hematologic cancer	6.93e-05	0.000725	CcSEcCtD
Probenecid—Dermatitis—Bortezomib—hematologic cancer	6.92e-05	0.000724	CcSEcCtD
Probenecid—Flushing—Prednisone—hematologic cancer	6.89e-05	0.000721	CcSEcCtD
Probenecid—Headache—Bortezomib—hematologic cancer	6.88e-05	0.00072	CcSEcCtD
Probenecid—Pain—Cisplatin—hematologic cancer	6.87e-05	0.000719	CcSEcCtD
Probenecid—Dermatitis—Bleomycin—hematologic cancer	6.87e-05	0.000718	CcSEcCtD
Probenecid—Hypersensitivity—Ifosfamide—hematologic cancer	6.87e-05	0.000718	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Methotrexate—hematologic cancer	6.85e-05	0.000717	CcSEcCtD
Probenecid—Vomiting—Vinorelbine—hematologic cancer	6.82e-05	0.000714	CcSEcCtD
Probenecid—Body temperature increased—Gemcitabine—hematologic cancer	6.81e-05	0.000713	CcSEcCtD
Probenecid—Dizziness—Thiotepa—hematologic cancer	6.78e-05	0.000709	CcSEcCtD
Probenecid—Dermatitis—Vinorelbine—hematologic cancer	6.76e-05	0.000707	CcSEcCtD
Probenecid—Headache—Vinorelbine—hematologic cancer	6.72e-05	0.000703	CcSEcCtD
Probenecid—Pollakiuria—Epirubicin—hematologic cancer	6.7e-05	0.000701	CcSEcCtD
Probenecid—Hypersensitivity—Vincristine—hematologic cancer	6.69e-05	0.0007	CcSEcCtD
Probenecid—Anaphylactic shock—Triamcinolone—hematologic cancer	6.68e-05	0.000698	CcSEcCtD
Probenecid—Pruritus—Alitretinoin—hematologic cancer	6.67e-05	0.000698	CcSEcCtD
Probenecid—Pruritus—Ifosfamide—hematologic cancer	6.59e-05	0.00069	CcSEcCtD
Probenecid—Haematuria—Methotrexate—hematologic cancer	6.59e-05	0.000689	CcSEcCtD
Probenecid—Alopecia—Prednisone—hematologic cancer	6.56e-05	0.000686	CcSEcCtD
Probenecid—Dizziness—Thalidomide—hematologic cancer	6.55e-05	0.000685	CcSEcCtD
Probenecid—Nausea—Bortezomib—hematologic cancer	6.53e-05	0.000683	CcSEcCtD
Probenecid—Hypersensitivity—Mitoxantrone—hematologic cancer	6.52e-05	0.000682	CcSEcCtD
Probenecid—Hypersensitivity—Irinotecan—hematologic cancer	6.52e-05	0.000682	CcSEcCtD
Probenecid—Vomiting—Thiotepa—hematologic cancer	6.52e-05	0.000681	CcSEcCtD
Probenecid—Nausea—Bleomycin—hematologic cancer	6.48e-05	0.000677	CcSEcCtD
Probenecid—Dermatitis—Thiotepa—hematologic cancer	6.46e-05	0.000675	CcSEcCtD
Probenecid—Headache—Thiotepa—hematologic cancer	6.42e-05	0.000671	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	6.41e-05	0.000671	CcSEcCtD
Probenecid—Decreased appetite—Etoposide—hematologic cancer	6.4e-05	0.000669	CcSEcCtD
Probenecid—Nausea—Vinorelbine—hematologic cancer	6.37e-05	0.000667	CcSEcCtD
Probenecid—Body temperature increased—Cisplatin—hematologic cancer	6.35e-05	0.000664	CcSEcCtD
Probenecid—Vomiting—Thalidomide—hematologic cancer	6.3e-05	0.000659	CcSEcCtD
Probenecid—Dizziness—Carmustine—hematologic cancer	6.29e-05	0.000658	CcSEcCtD
Probenecid—Pain—Etoposide—hematologic cancer	6.29e-05	0.000658	CcSEcCtD
Probenecid—Dermatitis—Thalidomide—hematologic cancer	6.24e-05	0.000653	CcSEcCtD
Probenecid—Dizziness—Alitretinoin—hematologic cancer	6.24e-05	0.000652	CcSEcCtD
Probenecid—Headache—Thalidomide—hematologic cancer	6.21e-05	0.000649	CcSEcCtD
Probenecid—Pain—Prednisolone—hematologic cancer	6.21e-05	0.000649	CcSEcCtD
Probenecid—Pollakiuria—Doxorubicin—hematologic cancer	6.2e-05	0.000649	CcSEcCtD
Probenecid—Haematuria—Epirubicin—hematologic cancer	6.17e-05	0.000645	CcSEcCtD
Probenecid—Dizziness—Ifosfamide—hematologic cancer	6.16e-05	0.000645	CcSEcCtD
Probenecid—Pruritus—Gemcitabine—hematologic cancer	6.1e-05	0.000638	CcSEcCtD
Probenecid—Nausea—Thiotepa—hematologic cancer	6.09e-05	0.000637	CcSEcCtD
Probenecid—Anaphylactic shock—Dexamethasone—hematologic cancer	6.06e-05	0.000634	CcSEcCtD
Probenecid—Anaphylactic shock—Betamethasone—hematologic cancer	6.06e-05	0.000634	CcSEcCtD
Probenecid—Vomiting—Carmustine—hematologic cancer	6.05e-05	0.000633	CcSEcCtD
Probenecid—Dizziness—Vincristine—hematologic cancer	6.01e-05	0.000628	CcSEcCtD
Probenecid—Dermatitis—Carmustine—hematologic cancer	6e-05	0.000627	CcSEcCtD
Probenecid—Vomiting—Alitretinoin—hematologic cancer	6e-05	0.000627	CcSEcCtD
Probenecid—Anaemia—Prednisone—hematologic cancer	5.97e-05	0.000625	CcSEcCtD
Probenecid—Headache—Carmustine—hematologic cancer	5.96e-05	0.000624	CcSEcCtD
Probenecid—Dermatitis—Alitretinoin—hematologic cancer	5.94e-05	0.000621	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	5.93e-05	0.000621	CcSEcCtD
Probenecid—Vomiting—Ifosfamide—hematologic cancer	5.93e-05	0.00062	CcSEcCtD
Probenecid—Hypersensitivity—Cisplatin—hematologic cancer	5.92e-05	0.000619	CcSEcCtD
Probenecid—Headache—Alitretinoin—hematologic cancer	5.91e-05	0.000618	CcSEcCtD
Probenecid—Nausea—Thalidomide—hematologic cancer	5.89e-05	0.000616	CcSEcCtD
Probenecid—Dermatitis—Ifosfamide—hematologic cancer	5.87e-05	0.000614	CcSEcCtD
Probenecid—Erythema multiforme—Methotrexate—hematologic cancer	5.87e-05	0.000614	CcSEcCtD
Probenecid—Dizziness—Irinotecan—hematologic cancer	5.85e-05	0.000612	CcSEcCtD
Probenecid—Urticaria—Etoposide—hematologic cancer	5.85e-05	0.000612	CcSEcCtD
Probenecid—Body temperature increased—Etoposide—hematologic cancer	5.82e-05	0.000609	CcSEcCtD
Probenecid—Vomiting—Vincristine—hematologic cancer	5.78e-05	0.000604	CcSEcCtD
Probenecid—Anorexia—Dexamethasone—hematologic cancer	5.77e-05	0.000604	CcSEcCtD
Probenecid—Anorexia—Betamethasone—hematologic cancer	5.77e-05	0.000604	CcSEcCtD
Probenecid—Urticaria—Prednisolone—hematologic cancer	5.77e-05	0.000603	CcSEcCtD
Probenecid—Dermatitis—Vincristine—hematologic cancer	5.72e-05	0.000599	CcSEcCtD
Probenecid—Pain—Triamcinolone—hematologic cancer	5.71e-05	0.000597	CcSEcCtD
Probenecid—Haematuria—Doxorubicin—hematologic cancer	5.71e-05	0.000597	CcSEcCtD
Probenecid—Headache—Vincristine—hematologic cancer	5.69e-05	0.000595	CcSEcCtD
Probenecid—Nausea—Carmustine—hematologic cancer	5.65e-05	0.000591	CcSEcCtD
Probenecid—Vomiting—Mitoxantrone—hematologic cancer	5.63e-05	0.000588	CcSEcCtD
Probenecid—Vomiting—Irinotecan—hematologic cancer	5.63e-05	0.000588	CcSEcCtD
Probenecid—Nausea—Alitretinoin—hematologic cancer	5.6e-05	0.000586	CcSEcCtD
Probenecid—Dermatitis—Mitoxantrone—hematologic cancer	5.57e-05	0.000583	CcSEcCtD
Probenecid—Dermatitis—Irinotecan—hematologic cancer	5.57e-05	0.000583	CcSEcCtD
Probenecid—Headache—Irinotecan—hematologic cancer	5.54e-05	0.00058	CcSEcCtD
Probenecid—Headache—Mitoxantrone—hematologic cancer	5.54e-05	0.00058	CcSEcCtD
Probenecid—Nausea—Ifosfamide—hematologic cancer	5.54e-05	0.000579	CcSEcCtD
Probenecid—Erythema multiforme—Epirubicin—hematologic cancer	5.49e-05	0.000574	CcSEcCtD
Probenecid—Alopecia—Methotrexate—hematologic cancer	5.48e-05	0.000574	CcSEcCtD
Probenecid—Vomiting—Gemcitabine—hematologic cancer	5.48e-05	0.000573	CcSEcCtD
Probenecid—Dermatitis—Gemcitabine—hematologic cancer	5.43e-05	0.000568	CcSEcCtD
Probenecid—Hypersensitivity—Etoposide—hematologic cancer	5.42e-05	0.000567	CcSEcCtD
Probenecid—Headache—Gemcitabine—hematologic cancer	5.4e-05	0.000565	CcSEcCtD
Probenecid—Nausea—Vincristine—hematologic cancer	5.4e-05	0.000565	CcSEcCtD
Probenecid—Flushing—Epirubicin—hematologic cancer	5.39e-05	0.000564	CcSEcCtD
Probenecid—Hypersensitivity—Prednisolone—hematologic cancer	5.35e-05	0.000559	CcSEcCtD
Probenecid—Urticaria—Triamcinolone—hematologic cancer	5.3e-05	0.000555	CcSEcCtD
Probenecid—Body temperature increased—Triamcinolone—hematologic cancer	5.28e-05	0.000552	CcSEcCtD
Probenecid—Anaphylactic shock—Prednisone—hematologic cancer	5.28e-05	0.000552	CcSEcCtD
Probenecid—Decreased appetite—Betamethasone—hematologic cancer	5.27e-05	0.000551	CcSEcCtD
Probenecid—Decreased appetite—Dexamethasone—hematologic cancer	5.27e-05	0.000551	CcSEcCtD
Probenecid—Nausea—Mitoxantrone—hematologic cancer	5.26e-05	0.00055	CcSEcCtD
Probenecid—Nausea—Irinotecan—hematologic cancer	5.26e-05	0.00055	CcSEcCtD
Probenecid—Pruritus—Etoposide—hematologic cancer	5.21e-05	0.000545	CcSEcCtD
Probenecid—Pain—Dexamethasone—hematologic cancer	5.18e-05	0.000542	CcSEcCtD
Probenecid—Pain—Betamethasone—hematologic cancer	5.18e-05	0.000542	CcSEcCtD
Probenecid—Alopecia—Epirubicin—hematologic cancer	5.13e-05	0.000537	CcSEcCtD
Probenecid—Nausea—Gemcitabine—hematologic cancer	5.12e-05	0.000536	CcSEcCtD
Probenecid—Vomiting—Cisplatin—hematologic cancer	5.11e-05	0.000534	CcSEcCtD
Probenecid—Erythema multiforme—Doxorubicin—hematologic cancer	5.08e-05	0.000531	CcSEcCtD
Probenecid—Dermatitis—Cisplatin—hematologic cancer	5.06e-05	0.000529	CcSEcCtD
Probenecid—Anorexia—Prednisone—hematologic cancer	5.03e-05	0.000526	CcSEcCtD
Probenecid—Anaemia—Methotrexate—hematologic cancer	4.99e-05	0.000522	CcSEcCtD
Probenecid—Flushing—Doxorubicin—hematologic cancer	4.99e-05	0.000522	CcSEcCtD
Probenecid—Hypersensitivity—Triamcinolone—hematologic cancer	4.92e-05	0.000514	CcSEcCtD
Probenecid—Dizziness—Etoposide—hematologic cancer	4.87e-05	0.000509	CcSEcCtD
Probenecid—Leukopenia—Methotrexate—hematologic cancer	4.84e-05	0.000506	CcSEcCtD
Probenecid—Urticaria—Dexamethasone—hematologic cancer	4.81e-05	0.000503	CcSEcCtD
Probenecid—Urticaria—Betamethasone—hematologic cancer	4.81e-05	0.000503	CcSEcCtD
Probenecid—Dizziness—Prednisolone—hematologic cancer	4.8e-05	0.000502	CcSEcCtD
Probenecid—Body temperature increased—Betamethasone—hematologic cancer	4.79e-05	0.000501	CcSEcCtD
Probenecid—Body temperature increased—Dexamethasone—hematologic cancer	4.79e-05	0.000501	CcSEcCtD
Probenecid—Nausea—Cisplatin—hematologic cancer	4.77e-05	0.000499	CcSEcCtD
Probenecid—Alopecia—Doxorubicin—hematologic cancer	4.75e-05	0.000497	CcSEcCtD
Probenecid—Pruritus—Triamcinolone—hematologic cancer	4.72e-05	0.000494	CcSEcCtD
Probenecid—Vomiting—Etoposide—hematologic cancer	4.68e-05	0.000489	CcSEcCtD
Probenecid—Anaemia—Epirubicin—hematologic cancer	4.67e-05	0.000489	CcSEcCtD
Probenecid—Dermatitis—Etoposide—hematologic cancer	4.64e-05	0.000485	CcSEcCtD
Probenecid—Headache—Etoposide—hematologic cancer	4.61e-05	0.000482	CcSEcCtD
Probenecid—Decreased appetite—Prednisone—hematologic cancer	4.59e-05	0.00048	CcSEcCtD
Probenecid—Dermatitis—Prednisolone—hematologic cancer	4.57e-05	0.000478	CcSEcCtD
Probenecid—Headache—Prednisolone—hematologic cancer	4.55e-05	0.000476	CcSEcCtD
Probenecid—Leukopenia—Epirubicin—hematologic cancer	4.53e-05	0.000473	CcSEcCtD
Probenecid—Dizziness—Triamcinolone—hematologic cancer	4.42e-05	0.000462	CcSEcCtD
Probenecid—Anaphylactic shock—Methotrexate—hematologic cancer	4.41e-05	0.000461	CcSEcCtD
Probenecid—Nausea—Etoposide—hematologic cancer	4.37e-05	0.000457	CcSEcCtD
Probenecid—Anaemia—Doxorubicin—hematologic cancer	4.32e-05	0.000452	CcSEcCtD
Probenecid—Nausea—Prednisolone—hematologic cancer	4.31e-05	0.000451	CcSEcCtD
Probenecid—Pruritus—Dexamethasone—hematologic cancer	4.29e-05	0.000448	CcSEcCtD
Probenecid—Pruritus—Betamethasone—hematologic cancer	4.29e-05	0.000448	CcSEcCtD
Probenecid—Vomiting—Triamcinolone—hematologic cancer	4.25e-05	0.000444	CcSEcCtD
Probenecid—Dermatitis—Triamcinolone—hematologic cancer	4.21e-05	0.00044	CcSEcCtD
Probenecid—Anorexia—Methotrexate—hematologic cancer	4.2e-05	0.00044	CcSEcCtD
Probenecid—Urticaria—Prednisone—hematologic cancer	4.19e-05	0.000438	CcSEcCtD
Probenecid—Leukopenia—Doxorubicin—hematologic cancer	4.19e-05	0.000438	CcSEcCtD
Probenecid—Headache—Triamcinolone—hematologic cancer	4.18e-05	0.000437	CcSEcCtD
Probenecid—Body temperature increased—Prednisone—hematologic cancer	4.17e-05	0.000436	CcSEcCtD
Probenecid—Anaphylactic shock—Epirubicin—hematologic cancer	4.13e-05	0.000432	CcSEcCtD
Probenecid—Dizziness—Dexamethasone—hematologic cancer	4.01e-05	0.000419	CcSEcCtD
Probenecid—Dizziness—Betamethasone—hematologic cancer	4.01e-05	0.000419	CcSEcCtD
Probenecid—Nausea—Triamcinolone—hematologic cancer	3.97e-05	0.000415	CcSEcCtD
Probenecid—Anorexia—Epirubicin—hematologic cancer	3.93e-05	0.000411	CcSEcCtD
Probenecid—Hypersensitivity—Prednisone—hematologic cancer	3.89e-05	0.000407	CcSEcCtD
Probenecid—Vomiting—Betamethasone—hematologic cancer	3.85e-05	0.000403	CcSEcCtD
Probenecid—Vomiting—Dexamethasone—hematologic cancer	3.85e-05	0.000403	CcSEcCtD
Probenecid—Decreased appetite—Methotrexate—hematologic cancer	3.83e-05	0.000401	CcSEcCtD
Probenecid—Anaphylactic shock—Doxorubicin—hematologic cancer	3.82e-05	0.000399	CcSEcCtD
Probenecid—Dermatitis—Dexamethasone—hematologic cancer	3.82e-05	0.000399	CcSEcCtD
Probenecid—Dermatitis—Betamethasone—hematologic cancer	3.82e-05	0.000399	CcSEcCtD
Probenecid—Headache—Betamethasone—hematologic cancer	3.8e-05	0.000397	CcSEcCtD
Probenecid—Headache—Dexamethasone—hematologic cancer	3.8e-05	0.000397	CcSEcCtD
Probenecid—Pain—Methotrexate—hematologic cancer	3.77e-05	0.000394	CcSEcCtD
Probenecid—Pruritus—Prednisone—hematologic cancer	3.73e-05	0.00039	CcSEcCtD
Probenecid—Anorexia—Doxorubicin—hematologic cancer	3.64e-05	0.000381	CcSEcCtD
Probenecid—Nausea—Dexamethasone—hematologic cancer	3.6e-05	0.000376	CcSEcCtD
Probenecid—Nausea—Betamethasone—hematologic cancer	3.6e-05	0.000376	CcSEcCtD
Probenecid—Decreased appetite—Epirubicin—hematologic cancer	3.59e-05	0.000375	CcSEcCtD
Probenecid—Pain—Epirubicin—hematologic cancer	3.53e-05	0.000369	CcSEcCtD
Probenecid—Urticaria—Methotrexate—hematologic cancer	3.5e-05	0.000366	CcSEcCtD
Probenecid—Dizziness—Prednisone—hematologic cancer	3.49e-05	0.000365	CcSEcCtD
Probenecid—Body temperature increased—Methotrexate—hematologic cancer	3.49e-05	0.000365	CcSEcCtD
Probenecid—Vomiting—Prednisone—hematologic cancer	3.35e-05	0.000351	CcSEcCtD
Probenecid—Dermatitis—Prednisone—hematologic cancer	3.32e-05	0.000348	CcSEcCtD
Probenecid—Decreased appetite—Doxorubicin—hematologic cancer	3.32e-05	0.000347	CcSEcCtD
Probenecid—Headache—Prednisone—hematologic cancer	3.31e-05	0.000346	CcSEcCtD
Probenecid—Urticaria—Epirubicin—hematologic cancer	3.28e-05	0.000343	CcSEcCtD
Probenecid—Pain—Doxorubicin—hematologic cancer	3.26e-05	0.000341	CcSEcCtD
Probenecid—Body temperature increased—Epirubicin—hematologic cancer	3.26e-05	0.000341	CcSEcCtD
Probenecid—Hypersensitivity—Methotrexate—hematologic cancer	3.25e-05	0.00034	CcSEcCtD
Probenecid—Nausea—Prednisone—hematologic cancer	3.13e-05	0.000328	CcSEcCtD
Probenecid—Pruritus—Methotrexate—hematologic cancer	3.12e-05	0.000326	CcSEcCtD
Probenecid—Hypersensitivity—Epirubicin—hematologic cancer	3.04e-05	0.000318	CcSEcCtD
Probenecid—Urticaria—Doxorubicin—hematologic cancer	3.03e-05	0.000317	CcSEcCtD
Probenecid—Body temperature increased—Doxorubicin—hematologic cancer	3.02e-05	0.000316	CcSEcCtD
Probenecid—Pruritus—Epirubicin—hematologic cancer	2.92e-05	0.000305	CcSEcCtD
Probenecid—Dizziness—Methotrexate—hematologic cancer	2.92e-05	0.000305	CcSEcCtD
Probenecid—Hypersensitivity—Doxorubicin—hematologic cancer	2.81e-05	0.000294	CcSEcCtD
Probenecid—Vomiting—Methotrexate—hematologic cancer	2.8e-05	0.000293	CcSEcCtD
Probenecid—Dermatitis—Methotrexate—hematologic cancer	2.78e-05	0.00029	CcSEcCtD
Probenecid—Headache—Methotrexate—hematologic cancer	2.76e-05	0.000289	CcSEcCtD
Probenecid—Dizziness—Epirubicin—hematologic cancer	2.73e-05	0.000285	CcSEcCtD
Probenecid—Pruritus—Doxorubicin—hematologic cancer	2.7e-05	0.000283	CcSEcCtD
Probenecid—Vomiting—Epirubicin—hematologic cancer	2.62e-05	0.000274	CcSEcCtD
Probenecid—Nausea—Methotrexate—hematologic cancer	2.62e-05	0.000274	CcSEcCtD
Probenecid—Dermatitis—Epirubicin—hematologic cancer	2.6e-05	0.000272	CcSEcCtD
Probenecid—Headache—Epirubicin—hematologic cancer	2.58e-05	0.00027	CcSEcCtD
Probenecid—Dizziness—Doxorubicin—hematologic cancer	2.52e-05	0.000264	CcSEcCtD
Probenecid—Nausea—Epirubicin—hematologic cancer	2.45e-05	0.000256	CcSEcCtD
Probenecid—Vomiting—Doxorubicin—hematologic cancer	2.43e-05	0.000254	CcSEcCtD
Probenecid—Dermatitis—Doxorubicin—hematologic cancer	2.41e-05	0.000252	CcSEcCtD
Probenecid—Headache—Doxorubicin—hematologic cancer	2.39e-05	0.00025	CcSEcCtD
Probenecid—Nausea—Doxorubicin—hematologic cancer	2.27e-05	0.000237	CcSEcCtD
Probenecid—Procainamide—SLC22A1—hematologic cancer	7.91e-06	0.686	CrCbGaD
Probenecid—Chlorpropamide—ABCB1—hematologic cancer	3.62e-06	0.314	CrCbGaD
Probenecid—ABCB1—Metabolism—SDC1—hematologic cancer	1.84e-06	2.46e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PIK3CB—hematologic cancer	1.83e-06	2.44e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PIK3CD—hematologic cancer	1.82e-06	2.44e-05	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.82e-06	2.44e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ENO2—hematologic cancer	1.81e-06	2.42e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—MTHFR—hematologic cancer	1.8e-06	2.42e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—PIK3CA—hematologic cancer	1.8e-06	2.41e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—ALB—hematologic cancer	1.8e-06	2.41e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—JAK2—hematologic cancer	1.8e-06	2.41e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.8e-06	2.41e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CD44—hematologic cancer	1.79e-06	2.4e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—NQO1—hematologic cancer	1.79e-06	2.4e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CD44—hematologic cancer	1.78e-06	2.39e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—NQO1—hematologic cancer	1.78e-06	2.39e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.77e-06	2.37e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—IL2—hematologic cancer	1.76e-06	2.36e-05	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.76e-06	2.35e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MDM2—hematologic cancer	1.76e-06	2.35e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—IDH2—hematologic cancer	1.76e-06	2.35e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HMMR—hematologic cancer	1.76e-06	2.35e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GSTT1—hematologic cancer	1.76e-06	2.35e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.76e-06	2.35e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.75e-06	2.34e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—CREBBP—hematologic cancer	1.73e-06	2.32e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.73e-06	2.31e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PIK3R1—hematologic cancer	1.72e-06	2.31e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—SDC1—hematologic cancer	1.72e-06	2.3e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MTOR—hematologic cancer	1.71e-06	2.29e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PIK3CB—hematologic cancer	1.71e-06	2.29e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—CD4—hematologic cancer	1.71e-06	2.28e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.7e-06	2.27e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CYCS—hematologic cancer	1.7e-06	2.27e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CYCS—hematologic cancer	1.69e-06	2.26e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	1.69e-06	2.26e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—HSP90AA1—hematologic cancer	1.68e-06	2.24e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—HRAS—hematologic cancer	1.67e-06	2.23e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.65e-06	2.21e-05	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	1.65e-06	2.2e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CD—hematologic cancer	1.64e-06	2.2e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.64e-06	2.19e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CG—hematologic cancer	1.63e-06	2.18e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—ALB—hematologic cancer	1.62e-06	2.17e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.62e-06	2.17e-05	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—AKT1—hematologic cancer	1.61e-06	2.15e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CA9—hematologic cancer	1.61e-06	2.15e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ACP5—hematologic cancer	1.61e-06	2.15e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—CDKN1B—hematologic cancer	1.6e-06	2.15e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—NQO1—hematologic cancer	1.6e-06	2.14e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CD44—hematologic cancer	1.6e-06	2.14e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—IL6—hematologic cancer	1.6e-06	2.14e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PIK3CB—hematologic cancer	1.59e-06	2.13e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.58e-06	2.12e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—EP300—hematologic cancer	1.58e-06	2.11e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PTEN—hematologic cancer	1.58e-06	2.11e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.57e-06	2.1e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CD44—hematologic cancer	1.56e-06	2.09e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—NQO1—hematologic cancer	1.56e-06	2.09e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3R1—hematologic cancer	1.55e-06	2.08e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.55e-06	2.07e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—SRC—hematologic cancer	1.54e-06	2.06e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.52e-06	2.03e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CG—hematologic cancer	1.52e-06	2.03e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CYCS—hematologic cancer	1.51e-06	2.03e-05	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—PIK3CA—hematologic cancer	1.51e-06	2.02e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—IDH1—hematologic cancer	1.51e-06	2.02e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—CREBBP—hematologic cancer	1.51e-06	2.02e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.51e-06	2.02e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—EP300—hematologic cancer	1.51e-06	2.01e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	1.5e-06	2.01e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—VEGFA—hematologic cancer	1.5e-06	2e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GSTP1—hematologic cancer	1.49e-06	2e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.49e-06	2e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—TXN—hematologic cancer	1.49e-06	2e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.49e-06	2e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GSTP1—hematologic cancer	1.49e-06	1.99e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—CDKN1A—hematologic cancer	1.48e-06	1.98e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—NRAS—hematologic cancer	1.48e-06	1.98e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYCS—hematologic cancer	1.48e-06	1.98e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PTEN—hematologic cancer	1.48e-06	1.98e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—AKT1—hematologic cancer	1.47e-06	1.97e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—HSP90AA1—hematologic cancer	1.47e-06	1.97e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.46e-06	1.96e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—NQO1—hematologic cancer	1.46e-06	1.95e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CD44—hematologic cancer	1.46e-06	1.95e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.45e-06	1.94e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.44e-06	1.92e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CB—hematologic cancer	1.43e-06	1.92e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CD—hematologic cancer	1.43e-06	1.91e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.43e-06	1.91e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—MAPK3—hematologic cancer	1.42e-06	1.89e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ABCB1—hematologic cancer	1.42e-06	1.89e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—ALB—hematologic cancer	1.41e-06	1.89e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—EP300—hematologic cancer	1.41e-06	1.89e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—ABCB1—hematologic cancer	1.41e-06	1.88e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—CREBBP—hematologic cancer	1.41e-06	1.88e-05	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PIK3CA—hematologic cancer	1.4e-06	1.88e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.4e-06	1.88e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYCS—hematologic cancer	1.38e-06	1.85e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PTEN—hematologic cancer	1.37e-06	1.84e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GSTM1—hematologic cancer	1.37e-06	1.84e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—NCOR1—hematologic cancer	1.37e-06	1.84e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TGFB1—hematologic cancer	1.37e-06	1.84e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	1.37e-06	1.84e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—SRC—hematologic cancer	1.37e-06	1.83e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GSTM1—hematologic cancer	1.37e-06	1.83e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—NCOR1—hematologic cancer	1.37e-06	1.83e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.37e-06	1.83e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.37e-06	1.83e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.35e-06	1.81e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3R1—hematologic cancer	1.35e-06	1.81e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GSTP1—hematologic cancer	1.33e-06	1.79e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CD—hematologic cancer	1.33e-06	1.78e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.33e-06	1.78e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—STAT3—hematologic cancer	1.32e-06	1.77e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—NRAS—hematologic cancer	1.32e-06	1.76e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—ALB—hematologic cancer	1.32e-06	1.76e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—EP300—hematologic cancer	1.31e-06	1.75e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GSTP1—hematologic cancer	1.3e-06	1.74e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.29e-06	1.73e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NUP98—hematologic cancer	1.29e-06	1.72e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—KRAS—hematologic cancer	1.27e-06	1.7e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ABCB1—hematologic cancer	1.26e-06	1.69e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MAPK3—hematologic cancer	1.26e-06	1.69e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3R1—hematologic cancer	1.26e-06	1.68e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.25e-06	1.67e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.25e-06	1.67e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CB—hematologic cancer	1.25e-06	1.67e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NUP214—hematologic cancer	1.24e-06	1.66e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PTEN—hematologic cancer	1.24e-06	1.66e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.23e-06	1.65e-05	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—AKT1—hematologic cancer	1.23e-06	1.65e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MYC—hematologic cancer	1.23e-06	1.64e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—NCOR1—hematologic cancer	1.23e-06	1.64e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GSTM1—hematologic cancer	1.23e-06	1.64e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—TGFB1—hematologic cancer	1.22e-06	1.64e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—MTR—hematologic cancer	1.22e-06	1.63e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.22e-06	1.63e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GSTP1—hematologic cancer	1.22e-06	1.63e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—MTHFR—hematologic cancer	1.21e-06	1.62e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—MTHFR—hematologic cancer	1.21e-06	1.62e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—NCOR1—hematologic cancer	1.2e-06	1.6e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GSTM1—hematologic cancer	1.2e-06	1.6e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ENO2—hematologic cancer	1.19e-06	1.6e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—EP300—hematologic cancer	1.18e-06	1.58e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.18e-06	1.58e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—PIK3CA—hematologic cancer	1.17e-06	1.56e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CB—hematologic cancer	1.16e-06	1.55e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.16e-06	1.55e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ABCB1—hematologic cancer	1.15e-06	1.54e-05	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—AKT1—hematologic cancer	1.15e-06	1.54e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—KRAS—hematologic cancer	1.13e-06	1.52e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SDC1—hematologic cancer	1.13e-06	1.51e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TP53—hematologic cancer	1.13e-06	1.51e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—NCOR1—hematologic cancer	1.12e-06	1.5e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GSTM1—hematologic cancer	1.12e-06	1.5e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PIK3CA—hematologic cancer	1.11e-06	1.49e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—MTHFR—hematologic cancer	1.08e-06	1.45e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—HRAS—hematologic cancer	1.08e-06	1.45e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PTEN—hematologic cancer	1.08e-06	1.44e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.07e-06	1.43e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.06e-06	1.42e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—MTHFR—hematologic cancer	1.06e-06	1.42e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PIK3CA—hematologic cancer	1.04e-06	1.39e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—EP300—hematologic cancer	1.03e-06	1.37e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CG—hematologic cancer	1.02e-06	1.37e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CG—hematologic cancer	1.01e-06	1.36e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PTEN—hematologic cancer	1e-06	1.34e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—MTHFR—hematologic cancer	9.88e-07	1.32e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PIK3CA—hematologic cancer	9.7e-07	1.3e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—HRAS—hematologic cancer	9.64e-07	1.29e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CD44—hematologic cancer	9.62e-07	1.29e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NQO1—hematologic cancer	9.62e-07	1.29e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—EP300—hematologic cancer	9.57e-07	1.28e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.55e-07	1.28e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—AKT1—hematologic cancer	9.55e-07	1.28e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CREBBP—hematologic cancer	9.46e-07	1.27e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CREBBP—hematologic cancer	9.4e-07	1.26e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—IL6—hematologic cancer	9.23e-07	1.23e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CG—hematologic cancer	9.1e-07	1.22e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYCS—hematologic cancer	9.1e-07	1.22e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—AKT1—hematologic cancer	9.1e-07	1.22e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	9.05e-07	1.21e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CD—hematologic cancer	8.97e-07	1.2e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CD—hematologic cancer	8.92e-07	1.19e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CG—hematologic cancer	8.89e-07	1.19e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ALB—hematologic cancer	8.85e-07	1.18e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CA—hematologic cancer	8.73e-07	1.17e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	8.71e-07	1.17e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—AKT1—hematologic cancer	8.51e-07	1.14e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3R1—hematologic cancer	8.47e-07	1.13e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CREBBP—hematologic cancer	8.44e-07	1.13e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3R1—hematologic cancer	8.42e-07	1.13e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CG—hematologic cancer	8.3e-07	1.11e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CREBBP—hematologic cancer	8.24e-07	1.1e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTP1—hematologic cancer	8.02e-07	1.07e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CD—hematologic cancer	8e-07	1.07e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—AKT1—hematologic cancer	7.92e-07	1.06e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ALB—hematologic cancer	7.9e-07	1.06e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CB—hematologic cancer	7.82e-07	1.05e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CD—hematologic cancer	7.81e-07	1.05e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CB—hematologic cancer	7.77e-07	1.04e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ALB—hematologic cancer	7.71e-07	1.03e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CREBBP—hematologic cancer	7.7e-07	1.03e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CA—hematologic cancer	7.6e-07	1.02e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ABCB1—hematologic cancer	7.6e-07	1.02e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3R1—hematologic cancer	7.56e-07	1.01e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3R1—hematologic cancer	7.38e-07	9.87e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NCOR1—hematologic cancer	7.37e-07	9.87e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTM1—hematologic cancer	7.37e-07	9.87e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CD—hematologic cancer	7.3e-07	9.77e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ALB—hematologic cancer	7.2e-07	9.64e-06	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—AKT1—hematologic cancer	7.13e-07	9.54e-06	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CA—hematologic cancer	7.08e-07	9.48e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CB—hematologic cancer	6.98e-07	9.34e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3R1—hematologic cancer	6.89e-07	9.22e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CB—hematologic cancer	6.81e-07	9.11e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PTEN—hematologic cancer	6.75e-07	9.04e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—PTEN—hematologic cancer	6.72e-07	8.99e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—MTHFR—hematologic cancer	6.52e-07	8.72e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—EP300—hematologic cancer	6.44e-07	8.62e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—EP300—hematologic cancer	6.4e-07	8.57e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CB—hematologic cancer	6.36e-07	8.51e-06	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—AKT1—hematologic cancer	6.21e-07	8.31e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PTEN—hematologic cancer	6.03e-07	8.07e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PTEN—hematologic cancer	5.88e-07	7.88e-06	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—AKT1—hematologic cancer	5.79e-07	7.74e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—EP300—hematologic cancer	5.75e-07	7.7e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—EP300—hematologic cancer	5.61e-07	7.51e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PTEN—hematologic cancer	5.5e-07	7.36e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CG—hematologic cancer	5.48e-07	7.33e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—EP300—hematologic cancer	5.24e-07	7.02e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CREBBP—hematologic cancer	5.08e-07	6.79e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CD—hematologic cancer	4.81e-07	6.44e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CA—hematologic cancer	4.76e-07	6.38e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ALB—hematologic cancer	4.75e-07	6.36e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CA—hematologic cancer	4.74e-07	6.34e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3R1—hematologic cancer	4.55e-07	6.08e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CA—hematologic cancer	4.25e-07	5.69e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CB—hematologic cancer	4.2e-07	5.62e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CA—hematologic cancer	4.15e-07	5.56e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—AKT1—hematologic cancer	3.89e-07	5.21e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CA—hematologic cancer	3.88e-07	5.19e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—AKT1—hematologic cancer	3.87e-07	5.18e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PTEN—hematologic cancer	3.63e-07	4.85e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—AKT1—hematologic cancer	3.47e-07	4.65e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—EP300—hematologic cancer	3.46e-07	4.63e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—AKT1—hematologic cancer	3.39e-07	4.54e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—AKT1—hematologic cancer	3.17e-07	4.24e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CA—hematologic cancer	2.56e-07	3.42e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—AKT1—hematologic cancer	2.09e-07	2.8e-06	CbGpPWpGaD
